Skip to main content
Bardia Nourbakhsh, MD, Neurology, Baltimore, MD, Johns Hopkins Hospital

BardiaNourbakhshMDMAS

Neurology • Baltimore, MD

Neuroimmunology/Multiple Sclerosis

Associate Professor of Neurology, Johns Hopkins University

Join to view full profile

Dr. Nourbakhsh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nourbakhsh's full profile

Already have an account?

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Neuroimmunology & Multiple Sclerosis, 2014 - 2017
  • UCSF
    UCSFMAS, Clinical Research , 2014 - 2016
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Neurology, 2010 - 2014
  • Tehran University of Medical Sciences School of Medicine
    Tehran University of Medical Sciences School of MedicineClass of 2007

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2020 - 2026
  • MD State Medical License
    MD State Medical License 2016 - 2025
  • CA State Medical License
    CA State Medical License 2013 - 2025
  • PA State Medical License
    PA State Medical License 2020 - 2022
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • American Brain Foundation Clinical Research Training Fellowship in MS American Academy of Neurology, 2014
  • Sylvia Lawry Clinical Research Fellowship National MS Society, 2014
  • Fred Baskin Young Investigator Award UT Southwestern, 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association between glutamate blockade and fatigue in patients with multiple sclerosis  
    Nourbakhsh B, Revirajan N, Wauabnt E, JAMA Neurology, 1/1/2015
  • Isoniazid in autoimmunity – A trigger for multiple sclerosis?  
    Nourbakhsh B, Stuve O, Ther Adv Neurol Disord, 1/1/2014
  • Pearls & Oysters: acute ischemic stroke caused by atypical thrombotic thrombocytopenic purpura  
    Rojas CR, Banerjee C; Siddiqui F, Nourbakhsh B, Powell CM, Neurology, 1/1/2013

Abstracts/Posters

  • Association between magnetic resonance imaging and cognitive outcomes in early multiple sclerosis.
    Nourbakhsh B, Nunan-Saah J, Maghzi A.-H, Julian J, Spain R, Pelletier D, Waubant, E, AAN Annual Meeting, 1/1/2015
  • Gray matter atrophy and physical and cognitive function in very early MS: a longitudinal study.
    Nourbakhsh B, Azevedo C, Nunan-Saah J, Maghzi A.-H, Spain R, Pelletier D, Waubant E, ECTRIMS Annual Meeting, 1/1/2015
  • Association of dietary salt intake and relapse rate in pediatric multiple sclerosis.
    Nourbakhsh B, Graves J, Lulu S, Waldman A, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema J.-M, Hart J, Lee M, Ness J, Rubin J, Krupp L, Gorman M, Benso..., ECTRIMS Annual Meeting, 1/1/2015
  • Join now to see all

Lectures

  • Gray Matter Atrophy and Physical and Cognitive Function in Early MS: A longitudinal study. 
    1/1/2015
  • Multiple Sclerosis, Gray Matter Disease and the Quest for Neuroprotection. 
    1/1/2014
  • A hypotonic infant; A case of Leigh Disease. 
    1/1/2013
  • Join now to see all

Press Mentions

  • COVID-19: Recommendations for Treating MS and Related Disorders
    COVID-19: Recommendations for Treating MS and Related DisordersMay 21st, 2020
  • Masters of Neurology: Focusing on Quality-of-Life
    Masters of Neurology: Focusing on Quality-of-LifeAugust 9th, 2017
  • Anticoagulants, Multiple Sclerosis Fatigue Studies Receive $5.5M in PCORI Funding
    Anticoagulants, Multiple Sclerosis Fatigue Studies Receive $5.5M in PCORI FundingJuly 29th, 2016
  • Join now to see all

Hospital Affiliations

Dr. Bardia Nourbakhsh, Dr. Bardia Nourbakhsh, MD, Dr. B Nourbakhsh